| Tag | Content |
|---|
EnhancerAtlas ID | HS177-01450 |
Organism | Homo sapiens |
Tissue/cell | SK-N-SH_RA |
Coordinate | chr1:161581670-161582810 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr1:161582764-161582782 | CCTCCCTTCCTTCCTTTG | - | 6.66 | | EWSR1-FLI1 | MA0149.1 | chr1:161582760-161582778 | CTTTCCTCCCTTCCTTCC | - | 9.01 | | KLF5 | MA0599.1 | chr1:161582351-161582361 | GGGGCGGGGC | - | 6.02 | | ZNF263 | MA0528.1 | chr1:161582760-161582781 | CTTTCCTCCCTTCCTTCCTTT | - | 6.12 | | ZNF263 | MA0528.1 | chr1:161582205-161582226 | TGAGGAGTGCGGGGGGGAAGA | + | 6.2 |
|
| | Number of super-enhancer constituents: 15 | ID | Coordinate | Tissue/cell |
| SE_07357 | chr1:161580788-161584698 | Brain_Hippocampus_Middle_150 | | SE_09867 | chr1:161579384-161583530 | CD14 | | SE_12235 | chr1:161581303-161583400 | CD3 | | SE_12654 | chr1:161581792-161582273 | CD34_adult | | SE_12771 | chr1:161581697-161581833 | CD34_fetal | | SE_12771 | chr1:161581912-161582301 | CD34_fetal | | SE_12771 | chr1:161582578-161582932 | CD34_fetal | | SE_13494 | chr1:161579645-161584358 | CD34_Primary_RO01536 | | SE_15335 | chr1:161579226-161584686 | CD4_Memory_Primary_7pool | | SE_16693 | chr1:161581295-161583416 | CD4_Naive_Primary_8pool | | SE_20036 | chr1:161580924-161584169 | CD56 | | SE_20740 | chr1:161577990-161584457 | CD8_Memory_7pool | | SE_22436 | chr1:161580812-161584433 | CD8_primiary | | SE_39938 | chr1:161580902-161584380 | K562 | | SE_53727 | chr1:161580858-161583334 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 161582451 | 161582780 | | chr1 | 161582212 | 161582506 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I161611 | chr1 | 161580791 | 161583390 |
|
Enhancer Sequence | AGAATTCAAA CATAATTGCT GGTTGGTTCA AATCAGGAGG AAAAGTAAGG ATGGAAAACA 60
TACGTTGTCA AAAGTGGGAT TCGAACCCAC GCCTCCAGCG GAGGGTGCGA TTTGAACGCA 120
GCGCCTTAAG ACTGCTCGGC CATCCTGACA CACGTTTTGC TAAACTTCCT AATTTCTCCT 180
AATTTTATCA TATACTGATG GTGCACGCTA TCAGGTCACA TTAATGTGTC TATTTACTGT 240
TTCAAATAAA ATTGTAACTC TCTCTAGACC TTGTCGCAAA GCGGGAAAAA TGAAACAGCC 300
TCCGACAGCT CTTTCCTCTT TCCTCACTAC CCAAACTAAA CCTTAAGGCT CCATTTTCCC 360
TGGCGACTCT TCGAGCGCCC CTCTGCTTCT GTAGAGGGGT CGAGCCATGT CAAGGTAGAC 420
CCTGTGTCGG CCCGTCTCCC TCGGATCCTC CGCACCAATC ACTGTTGCTG AATCCGACAC 480
CCGGCGGATC CAGTGCGGAG TCTCGAACAG CTGCGGAGCT GGGAGCTACG GGACATGAGG 540
AGTGCGGGGG GGAAGAGAAG ACGGCGGAGG AAAATCCCCC GGCGGTGCTC AACTGCGGCT 600
TTCTCTCTCG GCTGTGAGCC GGCTCCGCCC TCCGGCTTCC AGAGCAAGTG GCTTCTGCGT 660
TCACCGCCCC CCGCCGTTTG TGGGGCGGGG CCGATTCATA AGAATCGGTT CTCACCAATG 720
GAGGGCTTAG CATGTTTAAC CTCAGGATCA TAAACAAAAG ACACTGCTAG AACGGTCGGG 780
AAAGTCATAC GCTTTGCTTA TCTTATATAT AGATTTCTAA AATTCCAAAC CGGGGACGCG 840
TTGGTGGTGT AGTGGTGAGC ACAGCTGCCT TTCAAGCAGT TAACGCGGGT TCGATTCCCG 900
GGTAACGAAA CGTTTTTGTC TTTCCTTCTA CGAAAAACTT TTCTGAGCCG GAGCCTCCAG 960
CGCGCTGTGT ATTCGTTTTA CGCCTCAACG AAACTGCAGC AATACCTCAC TTTCCGTACT 1020
CGCTTCCTGT CTTTCCCCTG GCCTCTTTCT AAACCCAGGC TTTTTTTGAA GGGATTAAAT 1080
TCTGATGGTT CTTTCCTCCC TTCCTTCCTT TGTAAACTTC CAACTCTTGA GGAATCTTTG 1140
|
